Jean-Marc Herbert

Want to know more?

Graduate in engineering and Ph.D. in Biochemistry from the University of Clermont-Ferrand, France. He did his PhD in cellular biology and biochemistry at the Clinical Research Center, London, UK. Jean-Marc Herbert now has more than 30 years of industrial experience in pharmaceutical research and development. During 10 years, he worked as International Director of the Cardiovascular/thrombosis Research Department for Sanofi and Sanofi-Synthélabo Recherche. During this early phase of his career, he played significant roles in the discovery and development of Plavix(R) and Arixtra(R). In 2007-09, he was Senior VP, in charge of Discovery at Sanofi-Aventis Research. In 2009-15, he was leading a multinational group at Sanofi, based in Europe, US and China called “Early to Candidate” at the interface between academia and Pharma R&D. Jean-Marc Herbert is a member of several scientific international societies and of the editorial and review boards of several pier-reviewed top scientific journals. He has authored more than 400 papers and is listed as an inventor in more than 50 patents in various fields, including thrombosis, vascular biology, inflammation, cardiology and cancer.